A Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of a Single Injection of Rexlemestrocel-L Alone or Combined With Hyaluronic Acid (HA) in Subjects With Chronic Low Back Pain
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 02 Apr 2018
At a glance
- Drugs Rexlemestrocel-L (Primary) ; Hyaluronic acid
- Indications Back pain; Intervertebral disc degeneration
- Focus Registrational; Therapeutic Use
- Sponsors Mesoblast
- 28 Mar 2018 Status changed from recruiting to active, no longer recruiting.
- 27 Feb 2018 According to a Mesoblast media release, enrollment for this trial is expected to complete imminently (Q1 CY18).
- 22 Feb 2018 Status changed from active, no longer recruiting to recruiting.